4D MOLECULAR THERAPEUTICS
Live / Allowed — Notice of allowance issued (as of 27 Jan 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 31 May 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99211669
- Mark type
- Stylized text
- Filed
- 31 May 2025
- Published for opposition
- 02 Dec 2025
- Attorney of record
- Adam K Sacharoff
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development services of new pharmaceutical products; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of pharmaceutical preparations; Research and development in the field of biotechnology, genetic medicine, gene therapy, biologics, small molecules, DNA, RNA, proteins, vectors and payloads; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- 4D MOLECULAR THERAPEUTICS INC., Emeryville, CA, US
- 4D MOLECULAR THERAPEUTICS INC., Emeryville, CA, US
Prior registrations
Prosecution history
- 16 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 27 Jan 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Dec 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Dec 2025 — PUBLISHED FOR OPPOSITION
- 26 Nov 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Nov 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 03 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 24 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION E-MAILED
- 24 Oct 2025 — NON-FINAL ACTION WRITTEN
- 20 Oct 2025 — ASSIGNED TO EXAMINER
- 07 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 31 May 2025 — APPLICATION FILING RECEIPT MAILED